Analysis or telomere length in chronic myelogenous leukemia

Analysis or telomere length in chronic myelogenous leukemia

Bibliographic Details
Main Authors:	Fidler, C, Watkins, F, Snowball, J, Haynes, S, Kusec, R, Shepherd, P, Gaiger, A, Littlewood, T, Boultwood, J, Wainscoat, J
Format:	Journal article
Published:	1998

Similar Items

Analysis of telomere length in chronic myelogenous leukemia.
by: Boultwood, J, et al.
Published: (1997)

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.
by: Boultwood, J, et al.
Published: (1999)

Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.
by: Boultwood, J, et al.
Published: (2000)

Telomere length in myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (1995)

Telomere length in myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (1997)

Telomere length shortening in CML is associated with reduced time to accelerated phase but does not influence overall survival.
by: Boultwood, J, et al.
Published: (1999)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
by: Watkins, F, et al.
Published: (2004)

BRCA2 gene deletion is rare in chronic lymphocytic leukemia.
by: Pilozzi, E, et al.
Published: (1998)

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
by: Campbell, L, et al.
Published: (2006)

Amplification of mitochondrial DNA in CGL in transformation.
by: Fidler, C, et al.
Published: (1996)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (1996)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
by: Fidler, C, et al.
Published: (2004)

Chronic myelogenous leukemia on target
by: Veronika Némethová, et al.
Published: (2018-07-01)

Pathogenesis of chronic myelogenous leukemia
by: G Bergamaschi, et al.
Published: (1994-01-01)

Bosutinib in the management of chronic myelogenous leukemia
by: Keller-von Amsberg G, et al.
Published: (2013-05-01)

Individual Telomere Lengths in Chronic Myeloid Leukemia
by: Oumar Samassekou, et al.
Published: (2009-11-01)

CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
by: Lodovico Balducci
Published: (2014-05-01)

Apoptosis resistance in chronic myelogenous leukemia
by: Fabíola Attié de Castro, et al.
Published: (2005-09-01)

Chromosome Arm-Specific Long Telomeres: A New Clonal Event in Primary Chronic Myelogenous Leukemia Cells
by: Oumar Samassekou, et al.
Published: (2011-06-01)

Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
by: Pritish K Bhattacharyya
Published: (2013-01-01)

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
by: Boultwood, J, et al.
Published: (2010)

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
by: Boultwood, J, et al.
Published: (2010)

Adherence to deferoxamine therapy: Heeding hippocrates and osler
by: Watkins, F, et al.
Published: (2004)

A mathematical model of chronic myelogenous leukemia
by: Neiman, B
Published: (2000)

Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia
by: Gopalarethinam Janani, et al.
Published: (2023-09-01)

Green crystals of death in chronic myelogenous leukemia
by: Mohammad Esmaeil Khedmati, et al.
Published: (2022-01-01)

Wnt Signaling Pathway and Chronic Myelogenous Leukemia
by: HOU Yan, et al.
Published: (2019-02-01)

Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
by: Harnicar S, et al.
Published: (2014-08-01)

Glutathione S-transferase gene deletions in myelodysplasia.
by: Atoyebi, W, et al.
Published: (1997)

Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia
by: Atoyebi, W, et al.
Published: (1997)

AMPLIFICATION OF MITOCHONDRIAL-DNA IN ACUTE MYELOID-LEUKEMIA
by: Boultwood, J, et al.
Published: (1994)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004)

Chronic myelogenous leukemia: molecular monitoring in clinical practice
by: N. R. Ryabchikova, et al.
Published: (2014-07-01)

Unusual T-Lymphoblastic Blast Phase of Chronic Myelogenous Leukemia
by: Jie Xu, et al.
Published: (2014-01-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Chronic myelogenous leukemia: molecular monitoring in clinical practice
by: N. R. Ryabchikova, et al.
Published: (2014-07-01)

The treatment of pediatric chronic myelogenous leukemia in the imatinib era
by: Jae Wook Lee, et al.
Published: (2011-03-01)

Activation of the hedgehog pathway in chronic myelogeneous leukemia patients
by: Long Bing, et al.
Published: (2011-01-01)

Inflammation Promotes Oxidative and Nitrosative Stress in Chronic Myelogenous Leukemia
by: Dragoslava Đikić, et al.
Published: (2022-02-01)